SCHEMBL30183113

SCHEMBL30183113

CN1CCN(c2ccc(NC(=O)c3n[nH]c4c3C(C)(C)Cc3cnc(N)nc3-4)cc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 9/20 0.51
AURKA O14965 5/20 0.51
CCNA2 P20248 5/20 0.50
DYRK1A Q13627 3/20 0.50
EGFR P00533 3/20 0.50
LCK P06239 2/20 0.50
GAK O14976 1/20 0.50
BUB1 O43683 1/20 0.50
CCNT1 O60563 1/20 0.50
ULK1 O75385 1/20 0.50
STK16 O75716 1/20 0.50
PRKD3 O94806 1/20 0.50
LATS1 O95835 1/20 0.50
ABL1 P00519 1/20 0.50
NTRK1 P04629 1/20 0.50
FYN P06241 1/20 0.50
CDK1 P06493 1/20 0.50
YES1 P07947 1/20 0.50
LYN P07948 1/20 0.50
RET P07949 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20649258 1.00 CDK2 (0.51) CDK2AURKACCNA2DYRK1AEGFR
SCHEMBL20649379 0.88 FLT3 (0.51) CDK2AURKACCNA2DYRK1AEGFR
SCHEMBL30183993 0.88 FLT3 (0.51) CDK2AURKACCNA2DYRK1AEGFR
SCHEMBL30183109 0.87 PRKCI (0.39) CDK2AURKACCNA2DYRK1AEGFR
SCHEMBL20648989 0.87 PRKCI (0.39) CDK2AURKACCNA2DYRK1AEGFR
SCHEMBL20649197 0.87 PDGFRB (0.41) CDK2AURKACCNA2PDGFRBCDK4
SCHEMBL30183938 0.85 RARA (0.44) CDK2AURKACCNA2PDGFRBCDK4
SCHEMBL20648961 0.85 RARA (0.44) CDK2AURKACCNA2PDGFRBCDK4
SCHEMBL20649077 0.85 ATR (0.49) CDK2AURKADYRK1ACDK1AURKB
SCHEMBL30183541 0.85 ATR (0.49) CDK2AURKADYRK1ACDK1AURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110997678-B Pyrazoloquinazoline derivatives as choline kinase inhibitors 内尔维亚诺医疗科学公司 2023-02-21 CN claimed
CN-110997678-B Pyrazoloquinazoline derivatives as choline kinase inhibitors 内尔维亚诺医疗科学公司 2023-02-21 CN disclosed